Modular storage system
US-2026076476-A1 · Mar 19, 2026 · US
US10176735B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10176735-B2 |
| Application number | US-201314070104-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 1, 2013 |
| Priority date | Nov 30, 2012 |
| Publication date | Jan 8, 2019 |
| Grant date | Jan 8, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A packaged medication assembly includes a packaged medication, a bag, and an information insert. The packaged medication includes a container and medication enclosed within the container. The bag defines a first panel, a storage chamber, and an opening to the storage chamber. The information insert includes patient information, which provides identification of a patient that the medication was packaged for, and medication information providing at least one of an identity of and a description of the medication. The information insert includes a patient identifying section including the patient information adjacent the first edge. The information insert is placed in the storage chamber such that substantially only the patient identifying section extends and remains exposed above the first panel such that a remainder of the information insert is covered by the first panel of the bag. The packaged medication is positioned within the storage chamber.
Opening claim text (preview).
What is claimed is: 1. A packaged medication assembly comprising: a bag defining a bottom bag fold line, a first panel adjacent the bottom bag fold line, a storage chamber, and an opening to the storage chamber formed at least partially by a first edge of the first panel opposite the bottom bag fold line; and an information insert having a width smaller than a width of the first panel of the bag and a height greater than a height of the first panel of the bag, wherein: the height of the information insert is defined between a first edge of the information insert and a second edge of the information insert, the information insert includes patient information, which provides identification of a patient that a medication was packaged for, and medication information providing at least one of an identity of and a description of the medication, the information insert includes a patient identifying section including the patient information adjacent the first edge of the information insert, and a confidential medication information section below the patient identifying section that has a height less than the height of the first panel of the bag, wherein a physical perforated line separates the confidential medication section from remaining portion of the information insert including the patient identifying section, and the patient identifying section includes a computer readable code configured to identify prescription information by a computer when processing the packaged medication assembly, the information insert is placed in the storage chamber such that the second edge is positioned adjacent the bottom bag fold line and substantially only the patient identifying section of the information insert extends beyond and remains exposed above the first edge of the first panel of the bag while the confidential medication information section of the information insert remains concealed from view by the first panel of the bag so as to protect a privacy of the patient, and a packaged medication is positioned within the storage chamber behind the information insert relative to a front side of the information insert that contains the patient information. 2. The packaged medication assembly of claim 1 , wherein the patient identifying section is characterized by an absence of human readable information identifying the medication. 3. The packaged medication assembly of claim 1 , wherein the information insert is placed in the storage chamber such that the second edge is positioned in contact with the bottom bag fold line. 4. The packaged medication assembly of claim 1 , wherein the bag defines a second panel opposite the first panel, the second panel and the first panel intersecting one another at the bottom bag fold line. 5. The packaged medication assembly of claim 4 , wherein the bag defines a two side panels, the two side panels are positioned on opposing sides of the bag and each of the two side panels extends between the first panel and the second panel, each of the two side panels defines a corresponding longitudinal fold line extending from the bottom bag fold line to the opening of the bag, and each of the two side panels is folded into the storage chamber along the longitudinal fold line. 6. The packaged medication assembly of claim 5 , wherein each of the two side panels is divided into a first side panel section adjacent the first panel on one side of the corresponding longitudinal fold line and a second side panel section adjacent the second panel on the other side of the corresponding longitudinal fold line, and the information insert is positioned to extend between the first panel and the first side panel section of each of the two side panels. 7. The packaged medication assembly of claim 1 , wherein information insert includes a guest receipt section near the first edge of the information insert, and the guest receipt section includes the patient identifying section. 8. The packaged medication assembly of claim 7 , wherein the guest receipt section includes two guest receipts separated by a perforation line. 9. The packaged medication assembly of claim 1 , further comprising a pharmacy processing section bordering the information insert along a hard perforation line, the pharmacy processing section being folded about the hard perforation line when the information insert is positioned in the storage chamber of the bag. 10. The packaged medication assembly of claim 1 , wherein the patient identifying section includes a partial patient identifier and a complete patient name separate from the partial patient identifier, and the partial patient identifier is visually differentiated from all other information printed on the patient identifying section. 11. The packaged medication assembly of claim 1 , in combination with additional packaged medication assemblies, wherein the combination includes a bin selectively maintaining an array of packaged medication assemblies including the packaged medication assembly and the additional packaged medication assemblies such that the patient identifying section remains prominently positioned above the first panel of the bag while maintained in the array. 12. The packaged medication assembly of claim 4 , wherein a first portion of the opening of the bag is formed by the first panel opposite the bottom fold line, a second portion of the opening of the bag is formed by the second panel opposite the bottom fold line, and the second portion of the opening is located further away from the bottom fold line as compared to a location of the first portion of the opening such that more of the information insert is viewable above the first panel than is viewable above the second panel. 13. A pharmaceutical preparation system comprising: means for maintaining a drug for a patient; means for providing human-readable information about the drug and the patient, wherein the information about the drug is spatially separated from the information about the patient; and means for containing the means for maintaining the drug and the means for providing human-readable information such that the means for maintaining the drug is substantially entirely enclosed within the means for containing, wherein the means for providing human-readable information has a height greater than a height of the means for containing and is substantially entirely enclosed within the means for containing other than a first portion of the means for providing human-readable information, and the first portion of the means for providing human-readable information includes human-readable information about the patient but is void of any human-readable information identifying the drug, and the means for providing human-readable information includes a confidential second portion, wherein a physical perforated line separates the confidential second portion from remaining portion of the means for providing the human-readable information including the first portion, and the first portion includes a computer readable code configured to identify prescription information by a computer when processing the means for providing the human-readable information, the confidential second portion of the means for providing human-readable information includes human-readable information about the drug and has a height less than the height of the means for containing and thus is concealed from view by the means for containing so as to protect a privacy of the patient when the means for maintaining the drug is positioned behind the means for providing human-readable information relative to a front side of the means for providing human-readable information that contains the human-readable information.
for pills or tablets (containers for pills or tablets with special dispensing means therefor B65D83/04) · CPC title
Holders for containers · CPC title
on paper articles, e.g. booklets, newspapers · CPC title
Printed labels · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.